About the Authors
- Guillermo Horga
-
* E-mail: guillermo.horga@gmail.com
Affiliations Department of Psychiatry, New York State Psychiatric Institute, Columbia University Medical Center, New York, New York, United States of America, Schizophrenia Unit, Neuroscience Institute, Hospital Clinic of Barcelona, Barcelona, Spain, Department of Psychiatry and Clinical Psychobiology, University of Barcelona, Barcelona, Spain
- Emilio Fernández-Egea
-
Affiliations Department of Psychiatry, University of Cambridge, Cambridge, and the Cambridgeshire and Peterborough NHS Foundation Trust, Huntingdon, United Kingdom, Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Madrid, Spain
- Anna Mané
-
Affiliations Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Madrid, Spain, Centre Forum, Barcelona, Spain
- Mireia Font
-
Affiliation Schizophrenia Unit, Neuroscience Institute, Hospital Clinic of Barcelona, Barcelona, Spain
- Kelly C. Schatz
-
Affiliation Department of Psychiatry, New York State Psychiatric Institute, Columbia University Medical Center, New York, New York, United States of America
- Carles Falcon
-
Affiliation GIB-UB. CIBER-BBN, Barcelona, Spain
- Francisco Lomeña
-
Affiliations Schizophrenia Unit, Neuroscience Institute, Hospital Clinic of Barcelona, Barcelona, Spain, Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Madrid, Spain, Institut d′Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
- Miguel Bernardo
-
Affiliations Schizophrenia Unit, Neuroscience Institute, Hospital Clinic of Barcelona, Barcelona, Spain, Department of Psychiatry and Clinical Psychobiology, University of Barcelona, Barcelona, Spain, Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Madrid, Spain, Institut d′Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
- Eduard Parellada
-
Affiliations Schizophrenia Unit, Neuroscience Institute, Hospital Clinic of Barcelona, Barcelona, Spain, Department of Psychiatry and Clinical Psychobiology, University of Barcelona, Barcelona, Spain, Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Madrid, Spain, Institut d′Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
Competing Interests
Dr. Parellada declares having received grant support and lecture fees from Janssen- Cilag and GlaxoSmithKline, and grant support from Lilly. Dr. Lomeña±a declares having received lecture fees from GE Healthcare. Dr. Font declares having received grant support from Maraton TV3 and Janssen-Cilag and travel support from Janssen-Cilag. Dr. Bernardo declares having received grant support from Bristol-Myers Squibb, CIBERSAM, Eli Lilly, FIS-Institute of Health Carlos III, the Government of Catalonia, Janssen-Cilag, Marató TV3, Organon and Pfizer, and declares board membership with and lecture fees from Bristol-Myers Squibb, Eli Lilly, Janssen-Cilag, Mylan and Pfizer. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: GH EP FL EF-E MF MB. Performed the experiments: GH AM EF-E MF. Analyzed the data: GH AM KS CF. Wrote the paper: GH.